Stem cell derived exosome therapy for clinical management of lung damage in critically-ill corona viral pneumonia patients
Implementing Organization
Principal Investigator
Dr Naresh Kasoju
Scientist
|
Sree Chitra Tirunal Institute for Medical Sciences &Technology (SCTIMST), Thiruvananthapuram
About
This study hypothesized that the immuno-modulatory and the reparative properties of MSC-derived exosomal fractions will aid in controlling the cytokine storm and the lung tissue regeneration in the critically ill COVID-19 patients.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Scientist
Sree Chitra Tirunal Institute for Medical Sciences &Technology (SCTIMST), Thiruvananthapuram
Acces sibility Controls